Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

PD-1 Blockade on Tumor Microenvironment-Resident ILC2s Promotes TNF-α Production and Restricts Progression of Metastatic Melanoma

Frontiers in Immunology(2021)10.3389/fimmu.2021.733136Source: DataRank Database

PD-1 Blockade on Tumor Microenvironment-Resident ILC2s Promotes TNF-α Production and Restricts Progression of Metastatic Melanoma is a research paper published in Frontiers in Immunology (2021). On theSindex it has a DataRank of 0. It has been cited 27 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access27 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 1.46)OA: goldTopics (54)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Benjamin P. Hurrell ORCID,Doumet Georges Helou ORCID,Christine Quach ORCID,Jacob D. Painter ORCID,Pedram Shafiei-Jahani ORCID

Live enrichment

PubMed:34531874 OpenAlex:https://openalex.org/W3197695062

NHLBI NIH HHS

Grant: R01 HL144790

NIAID NIH HHS

Grant: P01 AI056299

NIAID NIH HHS

Grant: R01 AI145813

NIEHS NIH HHS

Grant: R01 ES025786

NIEHS NIH HHS

Grant: R01 ES021801

NHLBI NIH HHS

Grant: R01 HL151493

FWCI

1.46

Citation Percentile

0.8%

Citation Trend

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://doi.org/10.3389/fimmu.2021.733136

publisherhttps://doi.org/10.3389/fimmu.2021.733136

publisherhttps://www.frontiersin.org/articles/10.3389/fimmu.2021.733136/full

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34531874

repositoryhttp://europepmc.org/pmc/articles/PMC8438316

Fields of Study

IL-33, ST2, and ILC PathwaysEosinophilic EsophagitisImmune Cell Function and InteractionAnimalsCell Line, TumorDisease ProgressionHumansImmune Checkpoint InhibitorsLung NeoplasmsLymphocytesMelanoma, ExperimentalMice, Inbred BALB CMice, KnockoutProgrammed Cell Death 1 ReceptorSkin NeoplasmsTumor BurdenTumor MicroenvironmentTumor Necrosis Factor-alphaMice

MeSH Terms

Immune Checkpoint InhibitorsAnimalsHumansLung NeoplasmsLymphocytesMelanoma, ExperimentalMice, Inbred BALB CSkin NeoplasmsTumor Necrosis Factor-alphaMice, KnockoutDisease ProgressionCell Line, TumorTumor BurdenMiceTumor MicroenvironmentProgrammed Cell Death 1 Receptor

Keywords

Tumor microenvironmentImmunotherapyCancer researchCytotoxic T cellMedicineMelanomaCytokineTumor necrosis factor alphaInnate lymphoid cellCancerCancer immunotherapyImmunologyImmune systemBiologyAcquired immune systemInternal medicinePD-1TNF - αinnate lymphoid cell 2

Sustainable Development Goals

SDG 0: Good health and well-being